Earnings Update: Japan Lifeline Co., Ltd. (TSE:7575) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts

Last week, you might have seen that Japan Lifeline Co., Ltd. (TSE:7575) released its annual result to the market. The early response was not positive, with shares down 8.1% to JP¥1,424 in the past week. The result was positive overall - although revenues of JP¥57b were in line with what the analysts predicted, Japan Lifeline surprised by delivering a statutory profit of JP¥131 per share, modestly greater than expected. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Taking into account the latest results, the current consensus from Japan Lifeline's three analysts is for revenues of JP¥60.0b in 2026. This would reflect a credible 6.0% increase on its revenue over the past 12 months. Statutory per share are forecast to be JP¥134, approximately in line with the last 12 months. In the lead-up to this report, the analysts had been modelling revenues of JP¥61.5b and earnings per share (EPS) of JP¥143 in 2026. The analysts are less bullish than they were before these results, given the reduced revenue forecasts and the minor downgrade to earnings per share expectations.

Check out our latest analysis for Japan Lifeline

Despite the cuts to forecast earnings, there was no real change to the JP¥1,657 price target, showing that the analysts don't think the changes have a meaningful impact on its intrinsic value. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. There are some variant perceptions on Japan Lifeline, with the most bullish analyst valuing it at JP¥1,721 and the most bearish at JP¥1,600 per share. Still, with such a tight range of estimates, it suggeststhe analysts have a pretty good idea of what they think the company is worth.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. The analysts are definitely expecting Japan Lifeline's growth to accelerate, with the forecast 6.0% annualised growth to the end of 2026 ranking favourably alongside historical growth of 1.0% per annum over the past five years. Other similar companies in the industry (with analyst coverage) are also forecast to grow their revenue at 6.0% per year. Factoring in the forecast acceleration in revenue, it's pretty clear that Japan Lifeline is expected to grow at about the same rate as the wider industry.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Sadly, they also downgraded their revenue forecasts, but the business is still expected to grow at roughly the same rate as the industry itself. The consensus price target held steady at JP¥1,657, with the latest estimates not enough to have an impact on their price targets.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Japan Lifeline going out to 2028, and you can see them free on our platform here..

You can also see our analysis of Japan Lifeline's Board and CEO remuneration and experience, and whether company insiders have been buying stock.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.